[ccp4bb] Research Scientist Position - Vertex Pharmaceuticals (Europe) Ltd. - Oxford, UK

2013-02-14 Thread Jay Bertrand

Vertex Pharmaceuticals (Europe) Ltd has an immediate opening for a talented 
protein crystallographer in the Crystallography Group at our UK site (Abingdon, 
Oxfordshire). Candidates should have a PhD with productive 
post-doctoral/industrial employment experience in protein crystallography. The 
major role of the person will be to provide x-ray support to small molecule 
drug discovery and development by solving structures of protein-ligand 
complexes for structure-based drug design.


The position requires a broad background in protein crystallography and a solid 
understanding of biophysics and its application in drug discovery projects. 
Specifically, the required skills include the ability to design protein 
constructs for crystallization trials; protein crystallization using various 
techniques; data collection using a laboratory source and at the synchrotron; 
structure determination by molecular replacement, MIR and MAD; computing 
experience with a variety of crystallographic programs; the ability to 
interpret and communicate structural information. In addition, candidates 
should have a solid basic knowledge of chemistry and/or biochemistry. Excellent 
communication skills are required as is a strong ability to work in a team. 
Previous experience in the pharmaceutical industry would be considered an asset.

In return, you can look forward to an impressive benefits package that includes 
28 days holiday, employee stock purchase plan and group stakeholder pension. As 
you would expect, we are highly health-aware, so you will also be eligible for 
private medical, dental and optical insurance as well as life insurance. Plus 
you can take advantage of our work place nursery and gym membership.  If you 
are innovative and focused on achieving success within a collaborative 
environment, please visit our website.  To find out more information and apply, 
please visit 
http://bs.serving-sys.com/BurstingPipe/adServer.bs?cn=tfc=20mc=clickpli=6175807PluID=0ord=[timestamp]
The Science of Possibility.  Closing date for applications is 28 February 2013.

Vertex creates new possibilities in medicine. Our team discovers, develops and 
commercialises innovative therapies so people with serious diseases can lead 
better lives. Vertex scientists and our collaborators are working on new 
medicines to cure or significantly advance the treatment of hepatitis C, cystic 
fibrosis, epilepsy and other life-threatening diseases. Founded more than 20 
years ago in Cambridge, Mass., we now have ongoing worldwide research programs 
and sites in the United States, United Kingdom and Canada. Vertex has 
consistently been recognised as one of the industry's top workplaces by leading 
publications such as Science magazine, The Boston Globe, Boston Business 
Journal, San Diego Business Journal and The Scientist and most recently was 
named the top employer in Science magazine's 2011 annual survey. For more 
information and to view Vertex's press releases, please visit
www.vrtx.com

As the UK-based subsidiary, Vertex Pharmaceuticals Europe Ltd brings together 
scientists of multiple disciplines and various backgrounds to form a highly 
creative and productive team.  Our scientists work in an environment where 
chemists, biologists, structural biologist and computational chemists focus 
together on cancer and inflammatory diseases. Our research facility in 
Oxfordshire is equipped with the latest technology and together through 
collaboration of the wider organisation our world class teams are tackling the 
most ambitious projects in the industry.

VERTEX is an Equal Employment Opportunity/Affirmative Action employer. All 
employment decisions are made without regard to race, sex, national origin, 
colour, religion, age, disability, veteran status, genetic information or any 
other status protected by federal, state or local law.



Vertex Pharmaceuticals (Europe) Limited Registered in England and Wales, 
company no. 2907620 Registered Office: 88 Milton Park, Abingdon, Oxfordshire 
OX14 4RY, UK This email message and any attachments are confidential and 
intended for use by the addressee(s) only. If you are not the intended 
recipient, please notify me immediately by replying to this message, and 
destroy all copies of this message and any attachments. Thank you.


[ccp4bb] Renumbering and retaining state information pdb file

2013-02-14 Thread Amar Joshi
Hi,

I am trying to tidy up an old NMR structure (not mine) and I want to renumber 
the residues in all the states.
When I use pdbset starting at X, the numbers are changed but the state 
information is lost. How can I retain the state in my modified pdb file?

Thanks,
Amar

-
Amar Joshi Ph.D

Bayliss Lab
Department of Biochemistry
Henry Wellcome Building
University of Leicester
Lancaster Road, Leicester
LE1 9HN

Tel: 0116 229 7082
Email: aj...@leicester.ac.uk
--



Re: [ccp4bb] GeForce Graphics cards

2013-02-14 Thread Chris Richardson
On the subject of nVidia graphics cards, linux and stereo, I feel I ought to 
mention the Asus VG278H.

This is a 120Hz 27 1920x1080 monitor with a built-in nVidia 3D vision emitter, 
which comes bundled with a pair of 3D vision glasses.  The great thing about 
the built-in emitter is that it takes stereo synch from the DVI cable even 
under Linux.  This removes the need for a Quadro card with a 3-pin mini-DIN 
connector or 3-pin adapter.  Here in the UK our cheapest supplier was selling 
it for £380 ex. VAT.

There is little information about using it with Linux on the web, but as I 
understand it you still need a Quadro card. I got it running with little 
trouble using a Quadro 2000, Ubuntu 12.04 LTS and the latest nVidia drivers.  
It may be possible to use cheaper Quadro cards.  The picture and stereo quality 
is excellent when compared to our existing stereo systems.

Chris
--
Dr Chris Richardson :: Sysadmin, structural biology, 
icr.ac.ukhttp://icr.ac.uk/

The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company 
Limited by Guarantee, Registered in England under Company No. 534147 with its 
Registered Office at 123 Old Brompton Road, London SW7 3RP.

This e-mail message is confidential and for use by the addressee only.  If the 
message is received by anyone other than the addressee, please return the 
message to the sender by replying to it and then delete the message from your 
computer and network.

Re: [ccp4bb] GeForce Graphics cards

2013-02-14 Thread Joachim Reichelt
Yes, we have this monitor running fine on a Quadro FX 380.
Stereo is perfect using coot, pymol and many other SW.


[2262774.741] (==) NVIDIA(0): Using gamma correction (1.0, 1.0, 1.0)
[2262774.741] (**) NVIDIA(0): Option Stereo 10
[2262774.741] (**) NVIDIA(0): Option MetaModeOrientation clone
[2262774.741] (**) NVIDIA(0): USB IR emitter stereo requested
[2262774.741] (**) NVIDIA(0): Enabling 2D acceleration
[2262775.874] (II) NVIDIA(GPU-0): Display (Ancor Communications Inc ASUS 
VG278HR (DFP-0))
[2262775.875] (II) NVIDIA(GPU-0): supports NVIDIA 3D Vision stereo.
[2262775.997] (II) NVIDIA(0): NVIDIA GPU Quadro FX 380 (G96GL) at PCI:1:0:0 
(GPU-0)

Am 14.02.13 10:55, schrieb Chris Richardson:
On the subject of nVidia graphics cards, linux and stereo, I feel I ought to 
mention the Asus VG278H.

This is a 120Hz 27 1920x1080 monitor with a built-in nVidia 3D vision emitter, 
which comes bundled with a pair of 3D vision glasses.  The great thing about 
the built-in emitter is that it takes stereo synch from the DVI cable even 
under Linux.  This removes the need for a Quadro card with a 3-pin mini-DIN 
connector or 3-pin adapter.  Here in the UK our cheapest supplier was selling 
it for £380 ex. VAT.

There is little information about using it with Linux on the web, but as I 
understand it you still need a Quadro card. I got it running with little 
trouble using a Quadro 2000, Ubuntu 12.04 LTS and the latest nVidia drivers.  
It may be possible to use cheaper Quadro cards.  The picture and stereo quality 
is excellent when compared to our existing stereo systems.

Chris
--
Dr Chris Richardson :: Sysadmin, structural biology, 
icr.ac.ukhttp://icr.ac.uk/

The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company 
Limited by Guarantee, Registered in England under Company No. 534147 with its 
Registered Office at 123 Old Brompton Road, London SW7 3RP.

This e-mail message is confidential and for use by the addressee only. If the 
message is received by anyone other than the addressee, please return the 
message to the sender by replying to it and then delete the message from your 
computer and network.

--
Joachim Reichelt



Helmholtz-Zentrum für Infektionsforschung GmbH | Inhoffenstraße 7 | 38124 
Braunschweig | www.helmholtz-hzi.de

Vorsitzende des Aufsichtsrates: MinDir’in Bärbel Brumme-Bothe, 
Bundesministerium für Bildung und Forschung
Stellvertreter: Rüdiger Eichel, Abteilungsleiter Niedersächsisches Ministerium 
für Wissenschaft und Kultur
Geschäftsführung: Prof. Dr. Dirk Heinz; Ulf Richter, MBA
Gesellschaft mit beschränkter Haftung (GmbH)
Sitz der Gesellschaft: Braunschweig
Handelsregister: Amtsgericht Braunschweig, HRB 477


Re: [ccp4bb] observed reflections

2013-02-14 Thread Tim Gruene
-BEGIN PGP SIGNED MESSAGE-
Hash: SHA1

Dear Careina,

the number of observed reflections is the number of reflections your
integration software found on the images. If you compare this to the
theoretically possible number of reflections (calculated from the cell
and resolution limits), you come to the completeness of the dataset
and the multiplicity of reflections, both of which are quality
measures of the data set(s). Hence you should include the number in
the outer resolution shell, too.

Best,
Tim

On 02/14/2013 06:27 AM, Careina Edgooms wrote:
 Dear ccp4
 
 I apologise for the straightforward question. I'm just a bit
 confused about the observed reflections quoted in tables. What
 exactly is this and should it include outer shell separately?
 
 Best Careina

- -- 
- --
Dr Tim Gruene
Institut fuer anorganische Chemie
Tammannstr. 4
D-37077 Goettingen

GPG Key ID = A46BEE1A

-BEGIN PGP SIGNATURE-
Version: GnuPG v1.4.12 (GNU/Linux)
Comment: Using GnuPG with Mozilla - http://enigmail.mozdev.org/

iD8DBQFRHLkVUxlJ7aRr7hoRAhRvAKCHlihfMzDNGKCZYnOJROkaKOgY7QCgvxvs
0BuJ+WyLTYQtLKJ0TeB0TeI=
=ClBx
-END PGP SIGNATURE-


Re: [ccp4bb] S-nitrosylation protein

2013-02-14 Thread Savvas Savvides
Dear Uma,

A very complehensive survey of the state-of-the-art in this topic can be found 
in the following literature resources:

(1) 
Garman EF.
Radiation damage in macromolecular crystallography: what is it and why should 
we care?
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):339-51.

(2) 
The January 2013 issue of the Journal of Synchrotron Radiation featuring a 
special section with papers presented at last year's Intl workshop on X-ray 
damage of biological crystalline samples.
The annotated editorial by Garman and Weik in that issue is also very helpful.

Best regards
Savvas


On 13 Feb 2013, at 23:38, Uma Ratu wrote:

 Dear All:
  
 I plan to use X-ray crystallography method to study the S-nitrosylated 
 protein structure.
  
 The native protein crystals diffracted to 2A with synchrontron. I now have 
 the crystals of S-ntrosylated protein.
  
 Since S-NO moiety appears to be unstable to synchrotron radiation, could you 
 advice /  comments on the stratage on the data collection of S-nitrosylated 
 protein crystals?
  
 The protein crystals did not diffract well with in house X-ray.
  
 Thank you for your comments.
  
 Uma
 


Re: [ccp4bb] Renumbering and retaining state information pdb file

2013-02-14 Thread Ed. Pozharski
There should be many ways to do this.  You can split the file, renumber with 
pdbset, and then reassemble it.  This may be useful
http://strucbio.biologie.uni-konstanz.de/ccp4wiki/index.php/Useful_scripts_(aka_smart_piece_of_code)
Cheers, 
Ed

 Original message 
From: Amar Joshi aj...@leicester.ac.uk 
Date:  
To: CCP4BB@JISCMAIL.AC.UK 
Subject: [ccp4bb] Renumbering and retaining state information pdb file 
 
Hi,

I am trying to tidy up an old NMR structure (not mine) and I want to renumber 
the residues in all the states.
When I use pdbset starting at X, the numbers are changed but the state 
information is lost. How can I retain the state in my modified pdb file?

Thanks,
Amar

-
Amar Joshi Ph.D

Bayliss Lab
Department of Biochemistry
Henry Wellcome Building
University of Leicester
Lancaster Road, Leicester
LE1 9HN

Tel: 0116 229 7082
Email: aj...@leicester.ac.uk
--



Re: [ccp4bb] S-nitrosylation protein

2013-02-14 Thread Fischmann, Thierry
Collect small slices of data (instead of a complete data set) on several 
crystals then merge the data together to get a full data set.
The slices of must be small enough so that the damage to the S-NO group is 
still very limited on each slice. You may have to play with beam attenuation a 
bit, depending on how fast the degradation occurs.

Good luck

Thierry

From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of Uma Ratu
Sent: Wednesday, February 13, 2013 5:38 PM
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] S-nitrosylation protein

Dear All:

I plan to use X-ray crystallography method to study the S-nitrosylated protein 
structure.

The native protein crystals diffracted to 2A with synchrontron. I now have the 
crystals of S-ntrosylated protein.

Since S-NO moiety appears to be unstable to synchrotron radiation, could you 
advice /  comments on the stratage on the data collection of S-nitrosylated 
protein crystals?

The protein crystals did not diffract well with in house X-ray.

Thank you for your comments.

Uma
Notice:  This e-mail message, together with any attachments, contains
information of Merck  Co., Inc. (One Merck Drive, Whitehouse Station,
New Jersey, USA 08889), and/or its affiliates Direct contact information
for affiliates is available at 
http://www.merck.com/contact/contacts.html) that may be confidential,
proprietary copyrighted and/or legally privileged. It is intended solely
for the use of the individual or entity named on this message. If you are
not the intended recipient, and have received this message in error,
please notify us immediately by reply e-mail and then delete it from 
your system.


Re: [ccp4bb] S-nitrosylation protein

2013-02-14 Thread Uma Ratu
Dear All:

Many thanks for your commoents and advice.

I will keep them in mind.

Uma

On Thu, Feb 14, 2013 at 7:54 AM, Fischmann, Thierry 
thierry.fischm...@merck.com wrote:

  Collect small slices of data (instead of a complete data set) on several
 crystals then merge the data together to get a full data set.

 The slices of must be small enough so that the damage to the S-NO group is
 still very limited on each slice. You may have to play with beam
 attenuation a bit, depending on how fast the degradation occurs.

 ** **

 Good luck

 ** **

 Thierry

 ** **

 *From:* CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] *On Behalf Of *Uma
 Ratu
 *Sent:* Wednesday, February 13, 2013 5:38 PM

 *To:* CCP4BB@JISCMAIL.AC.UK
 *Subject:* [ccp4bb] S-nitrosylation protein

 ** **

 Dear All:

  

 I plan to use X-ray crystallography method to study the S-nitrosylated
 protein structure. 

  

 The native protein crystals diffracted to 2A with synchrontron. I now have
 the crystals of S-ntrosylated protein. 

  

 Since S-NO moiety appears to be unstable to synchrotron radiation, could
 you advice /  comments on the stratage on the data collection of
 S-nitrosylated protein crystals? 

  

 The protein crystals did not diffract well with in house X-ray. 

  

 Thank you for your comments. 

  

 Uma

 Notice:  This e-mail message, together with any attachments, contains
 information of Merck  Co., Inc. (One Merck Drive, Whitehouse Station,
 New Jersey, USA 08889), and/or its affiliates Direct contact information
 for affiliates is available at
 http://www.merck.com/contact/contacts.html) that may be confidential,
 proprietary copyrighted and/or legally privileged. It is intended solely
 for the use of the individual or entity named on this message. If you are
 not the intended recipient, and have received this message in error,
 please notify us immediately by reply e-mail and then delete it from
 your system.



Re: [ccp4bb] UWM is seeking testers for a new protein expression kit

2013-02-14 Thread Jessica Silvaggi
Hello everyone,

Thanks for the great interest in the kit, I have at least 30 requests already.  
For those of you asking about next steps, it will be for me to send a material 
transfer agreement for you and your office to sign.  I will need the contact 
information, email, phone, University name and address.  Once this is complete, 
I can send the kit.

Due to the overwhelming response, it will be most appreciated if people are 
willing to pay for the shipping on dry ice.  We generally use Fed Ex, but have 
used UPS as well.

Thanks again,

Jessica

Jessica Silvaggi, Ph.D.
Licensing Manager
UWM Research Foundation
Phone: 414-906-4654
Mobile: 508-769-5171
jsilva...@uwmfdn.orgmailto:jsilva...@uwmfdn.org
1440 East North Ave.
Milwaukee, WI 53202

From: Jessica Silvaggi
Sent: Wednesday, February 13, 2013 3:41 PM
To: 'CCP4BB@JISCMAIL.AC.UK'
Subject: UWM is seeking testers for a new protein expression kit

Hi everyone,

Dr. M.L.P. Collins at the University of Wisconsin-Milwaukee has developed a new 
method for making large quantities of active, viable proteins using 
Rhodospirillum rubrum as a host.  R. Rubrum is a bacterium that has 
traditionally been studied for its simple photosynthetic system, has 
demonstrated recent success in expressing high-yield protein.

To provide a brief overview, R. rubrum possesses the unique characteristic of 
forming an intracytoplasmic membrane (ICM) in response to membrane protein 
synthesis. The ICM is non-essential for growth and can incorporate foreign and 
over-expressed membrane proteins without disrupting normal cellular function. 
This characteristic has stimulated the expression of active and correctly 
folded membrane protein where other systems have failed.

In an attempt to gather additional testing data, the UWM Research Foundation 
would like to provide FREE protein expression kits to laboratories or 
universities that are having difficulties with their current method of 
producing large-scale proteins. Having limited resources, our researchers have 
only had the ability to test a number of proteins but thus far have seen 
exceptional promise. We currently have 8 other universities or companies using 
the new kit and are now ready to distribute to other participants. The link 
listed below provides a more detailed explanation of the testing process 
including the specific proteins currently being tested. You may also view Dr. 
Collin's publication on her findings of using R. rubrum as a host. If you are 
interested in learning more about this new system or have any additional 
comments, you may email me at jsilva...@uwmfdn.orgmailto:jsilva...@uwmfdn.org.

Testing Kit Link Slides

http://www.uwmresearchfoundation.org/getdoc/2a36a544-e47c-442e-baaf-9fb3442694f0/Slides-for-Kit-Testing-2013.aspx


Dr. Collin's Publication
Butzin, N.C; Owen, H.A.; and M.L.P. Collins. 2010. A new system for 
heterologous expression of membrane proteins: Rhodospirillum rubrum. Protein 
Expression and Purification, 70: 88-94.
http://www4.uwm.edu/letsci/biologicalsciences/facultystaff/collins/upload/Butzin_et_al_2010.pdf




[ccp4bb] how to add atoms in refmac library

2013-02-14 Thread Faisal Tarique
Dear all

My protein has Zinc atom but the refmac does not identifies it during
refinement..Can anybody please tell me how to add Zinc atom into the refmac
library for the successful refinement of the coordinates.

-- 
Regards

Faisal
School of Life Sciences
JNU


[ccp4bb] Thanks for the new graphical CCP4 installer

2013-02-14 Thread Francois Berenger

It is easy to use and even nice looking.

Regards,
F.